Do metabolic derangements in end-stage polycystic kidney disease differ versus other primary kidney diseases?
Open Access
- 22 September 2016
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 23 (1), 31-36
- https://doi.org/10.1111/nep.12927
Abstract
Aim Autosomal dominant polycystic kidney disease (ADPKD), a systemic disorder caused by mutation in genes encoding polycystins, has been reported to lead to metabolic derangements including new‐onset diabetes mellitus after kidney transplantation. We analyzed markers of insulin resistance (IR), inflammation, nutritional status and insulin‐like growth factor‐1 (IGF‐1) in end‐stage renal disease (ESRD) patients with ADPKD and ESRD patients with other primary kidney diseases. Methods In a post hoc cross‐sectional analysis in 254 non‐diabetic CKD 5 patients starting on dialysis, glucose metabolism (insulin, IGF‐1, homeostasis model assessment of IR, HOMA‐IR), inflammation (high sensitivity C‐reactive protein, interleukin‐6, and tumour necrosis factor), nutritional status, and bone mineral density (BMD), were assessed. Survival was recorded for median time of 28 months (IQR 15–48 months). Results Neither indices of IR, nor IGF‐1, inflammatory status, nutritional status, or BMD were different in patients with ADPKD as compared to other aetiologies of ESRD. Kaplan–Meier curves showed better survival among the ADPKD group versus other aetiologies, even after an exclusion of diabetic patients. Conclusions The ESRD phenotype did not differ in ADPKD versus other primary kidney diseases in terms of markers of IR, inflammation, and nutritional status. This argues against the proposition that ADPKD patients are more prone to develop metabolic derangements beyond those generally observed in advanced CKD. However, additional studies are warranted to further elucidate systemic metabolic aspects of ADPKD.Keywords
This publication has 19 references indexed in Scilit:
- Inflammation and Lipid Signaling in the Etiology of Insulin ResistanceCell Metabolism, 2012
- New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: A retrospective cohort studyNephrology, 2011
- Incidence and Risk Factors of Glucose Metabolism Disorders in Kidney Transplant Recipients: Role of Systematic Screening by Oral Glucose Tolerance TestTransplantation, 2011
- Inflammation, Oxidative Stress, and Insulin Resistance in Polycystic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2011
- Polycystic Kidney Disease Is a Risk Factor for New-Onset Diabetes After TransplantationTransplantation, 2007
- Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantationKidney International, 2005
- Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in ratsKidney International, 2001
- Coordinate Expression of the Autosomal Dominant Polycystic Kidney Disease Proteins, Polycystin-2 And Polycystin-1, in Normal and Cystic TissueThe American Journal of Pathology, 1999
- Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failureKidney International, 1999
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985